Martin Gleave
Martin Gleave
Professor of Urologic Sciences, University of British Columbia
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ubc.ca - Αρχική σελίδα
ΤίτλοςΠαρατίθεται απόΈτος
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ...
Autophagy 8 (4), 445-544, 2012
6123*2012
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, ...
Autophagy 4 (2), 151-175, 2008
23712008
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
JA Locke, ES Guns, AA Lubik, HH Adomat, SC Hendy, CA Wood, ...
Cancer research 68 (15), 6407-6415, 2008
7502008
Cumulative association of five genetic variants with prostate cancer
SL Zheng, J Sun, F Wiklund, S Smith, P Stattin, G Li, HO Adami, FC Hsu, ...
New England Journal of Medicine 358 (9), 910-919, 2008
6612008
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development
M Gironella, M Seux, MJ Xie, C Cano, R Tomasini, J Gommeaux, S Garcia, ...
Proceedings of the National Academy of Sciences 104 (41), 16170-16175, 2007
5992007
Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells
HC Wu, JT Hsieh, ME Gleave, NM Brown, S Pathak, LWK Chung
International journal of cancer 57 (3), 406-412, 1994
5321994
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer
EA Mostaghel, ST Page, DW Lin, L Fazli, IM Coleman, LD True, ...
Cancer research 67 (10), 5033-5041, 2007
5242007
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
M Gleave, JT Hsieh, C Gao, AC Von Eschenbach, LWK Chung
Cancer research 51 (14), 3753-3761, 1991
5181991
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...
Cancer discovery 1 (6), 487-495, 2011
4952011
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ...
The EMBO journal 30 (13), 2719-2733, 2011
4062011
Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells
DJ Mulholland, N Kobayashi, M Ruscetti, A Zhi, LM Tran, J Huang, ...
Cancer research 72 (7), 1878-1889, 2012
3912012
Active surveillance of small renal masses: progression patterns of early stage kidney cancer
MAS Jewett, K Mattar, J Basiuk, CG Morash, SE Pautler, DR Siemens, ...
European urology 60 (1), 39-44, 2011
3882011
Antisense therapy for cancer
ME Gleave, BP Monia
Nature Reviews Cancer 5 (6), 468, 2005
3752005
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report
SL Goldenberg, N Bruchovsky, ME Gleave, LD Sullivan, K Akakura
Urology 45 (5), 839-845, 1995
3521995
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer
P Rocchi, A So, S Kojima, M Signaevsky, E Beraldi, L Fazli, A Hurtado-coll, ...
Cancer research 64 (18), 6595-6602, 2004
3302004
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma
ME Gleave, M Elhilali, Y Fradet, I Davis, P Venner, F Saad, LH Klotz, ...
New England Journal of Medicine 338 (18), 1265-1271, 1998
3161998
Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects
ME GLEAVE, SL GOLDENBERG, JL CHIN, J WARNER, F SAAD, ...
The Journal of urology 166 (2), 500-507, 2001
3082001
Regulation of tumor angiogenesis by integrin-linked kinase (ILK)
C Tan, S Cruet-Hennequart, A Troussard, L Fazli, P Costello, K Sutton, ...
Cancer cell 5 (1), 79-90, 2004
3052004
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer
KN Chi, E Eisenhauer, L Fazli, EC Jones, SL Goldenberg, J Powers, D Tu, ...
Journal of the National Cancer Institute 97 (17), 1287-1296, 2005
2902005
Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer
AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ...
Clinical cancer research 21 (10), 2315-2324, 2015
2892015
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20